comparemela.com

Latest Breaking News On - Cancer therapy advisor - Page 4 : comparemela.com

Real-World Data Confirm Lack of Standard Care for Triple-Exposed Multiple Myeloma

Real-world data confirm a lack of standard treatment and poor outcomes for patients with triple-class-exposed relapsed/refractory multiple myeloma.

United statesUniversitaire ziekenhuizen leuvenMichel delforgeCancer therapy advisorTandem meetingsNorth america

Risks for Relapse Revealed in Multiethnic Study of Patients With Acute Lymphoblastic Leukemia

Among ALL patients who were MRD negative, Latino patients were more likely to relapse than non-Latino White patients.

United statesBaylor college of medicinePagna sokLatino whiteCancer therapy advisorBaylor collegeReducing ethnic disparitiesAcute leukemia

Predictors of Mortality During Hospital Stays in Patients With Multiple Myeloma

Infection, bleeding, and thromboembolic events appear to be the leading predictors of mortality during hospital stays in patients with multiple myeloma.

United statesCancer therapy advisorNationwide readmissions database

Biomarkers May Help Guide Treatment in Cancer Patients With COVID-19

A systematic review has revealed biomarkers that may provide prognostic insight and guide treatment in patients with cancer and COVID-19.

Cancer therapy advisor

Combo Appears Effective After Anti-PD-1 Failure in Advanced Melanoma

Ipilimumab plus nivolumab demonstrated efficacy in a phase 2 trial of patients with advanced melanoma who failed prior anti-PD-1 therapy.

United statesNational cancer instituteCancer centerCancer therapy advisorWest cancer centerNational cancer

vimarsana © 2020. All Rights Reserved.